Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach
- PMID: 9618745
- DOI: 10.1016/s0301-0082(98)00006-9
Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach
Abstract
This paper provides an overview of the compensatory mechanisms which come into action during experimental and human parkinsonism. The intrinsic properties of the dopaminergic neurones of the substantia nigra pars compacta (SNc) which degenerate during Parkinson's disease are described in detail. It is generally considered that the nigrostriatal pathway is principally responsible for the compensatory preservation of dopaminergic function. It is also becoming clear that the morphological characteristics of dopaminergic neurones and the dual character, synaptic and asynaptic, of striatal dopaminergic innervation engender two modes of transmission, wiring and volume, and that both these modes play a role in the preservation of dopaminergic function. The plasticity of the dopamine neurones, extrinsic or intrinsic to the striatum, can thus be regarded as another compensatory mechanism. Recent anatomical and electrophysiological studies have shown that the SNc receives both glutamatergic and cholinergic inputs. The dynamic role this innervation plays in compensatory mechanisms in the course of the disease is explained and discussed. Recent developments in the field of compensatory mechanisms speak for the urgence to develop a valid chronic model of Parkinson's disease, integrating all the clinical features, even resting tremor, and illustrating the gradual evolution of nigral degeneration observed in human Parkinson's disease. Only a dynamic approach to the physiopathological study of compensatory mechanisms in the basal ganglia will be capable of elucidating these complex questions.
Similar articles
-
Experimental models of Parkinson's disease: from the static to the dynamic.Rev Neurosci. 1998;9(2):71-90. doi: 10.1515/revneuro.1998.9.2.71. Rev Neurosci. 1998. PMID: 9711900 Review.
-
Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.Ann Neurol. 1995 Feb;37(2):265-72. doi: 10.1002/ana.410370219. Ann Neurol. 1995. PMID: 7847868
-
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated.Trends Neurosci. 2003 Apr;26(4):215-21. doi: 10.1016/S0166-2236(03)00038-9. Trends Neurosci. 2003. PMID: 12689773 Review.
-
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196. Brain. 2013. PMID: 23884809
-
Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.Exp Neurol. 2017 Dec;298(Pt B):148-161. doi: 10.1016/j.expneurol.2017.10.002. Epub 2017 Oct 4. Exp Neurol. 2017. PMID: 28987461 Review.
Cited by
-
The impact of a parkinsonian lesion on dynamic striatal dopamine transmission depends on nicotinic receptor activation.Neurobiol Dis. 2015 Oct;82:262-268. doi: 10.1016/j.nbd.2015.06.015. Epub 2015 Jun 25. Neurobiol Dis. 2015. PMID: 26117304 Free PMC article.
-
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.J Neurosci. 2001 Sep 1;21(17):6853-61. doi: 10.1523/JNEUROSCI.21-17-06853.2001. J Neurosci. 2001. PMID: 11517273 Free PMC article.
-
Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro.Peptides. 2014 Apr;54:1-8. doi: 10.1016/j.peptides.2013.12.007. Epub 2014 Jan 7. Peptides. 2014. PMID: 24406899 Free PMC article.
-
Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeys.PLoS One. 2012;7(11):e50842. doi: 10.1371/journal.pone.0050842. Epub 2012 Nov 30. PLoS One. 2012. PMID: 23226401 Free PMC article.
-
Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia.Neurobiol Aging. 2008 Mar;29(3):379-96. doi: 10.1016/j.neurobiolaging.2006.10.012. Epub 2006 Nov 27. Neurobiol Aging. 2008. PMID: 17125886 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous